The launch of a 750mcg teriparatide injection in Australia has gradually impacted treatment options for patients with severe osteoporosis . Currently , this higher dosage formulation is obtainable through limited physicians and hospitals nationwide , depending on strict prescription guidelines. Sales figures for the 750mcg dose remain moderately lo